AdaptHealth Corp. AHCO
7.66 USD -0.14 (-1.81%)
Nov 12, 2026, 1:08 PM EST
7.62 Day range 7.89
5.21 52-week range 13.43
- YTD
- -23.10%
- 1 year
- -17.82%
News
seekingalpha.com AdaptHealth Corp. (AHCO) Presents at 2026 UBS Global Healthcare Conference Transcript AdaptHealth Corp. ( AHCO ) 2026 UBS Global Healthcare Conference November 10, 2026 2:45 PM EST Company Participants Suzanne Foster - CEO & Director Conference Call Participants Kevin Caliendo - UBS…
benzinga.com Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8 Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $7 to $8.
benzinga.com UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9 UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.
benzinga.com AdaptHealth Q3 2026 Earnings Call Transcript AdaptHealth (NASDAQ:AHCO) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $2.850 billion-$2.890 billion to $2.880 billion-$2.900 billion vs $2.955 billion estimate.
benzinga.com AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $745.648 million which missed the analyst consensus estimate of $746.446 million by 0.11 percent. This is a 9.10 percent decrease over sales of…- benzinga.com Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9 Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
benzinga.com AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and- benzinga.com UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10 UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
- benzinga.com RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8 RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.
benzinga.com Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9 Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares…
benzinga.com Crude Oil Down Over 5%; McDonald's Earnings Top Views U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's…- benzinga.com UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
benzinga.com AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate.- benzinga.com AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $0.18 by 650 percent. This is a 1090 percent decrease over earnings of $0.10…
benzinga.com This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.
benzinga.com Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13 Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises the price target from $11 to $13.- benzinga.com Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.…
benzinga.com AdaptHealth Divests Diabetes Health Business To Cardinal Health For $235M In Cash Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businessesSharpens strategic focus on businesses where the…
benzinga.com AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems AdaptHealth disclosed a material cyberattack involving patient data and insurance billing passwords while saying operations remain unaffected.
benzinga.com IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating changes, see analyst ratings page.- benzinga.com Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $15 Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $18 to $15.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…- benzinga.com RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15 RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $13 to $15.
- benzinga.com Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16 Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $16.
- benzinga.com UBS Maintains Buy on AdaptHealth, Lowers Price Target to $14 UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $15 to $14.
- benzinga.com CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is unchanged from the same period last year. The…
- benzinga.com AdaptHealth Raises FY2026 Sales Guidance from $3.440B-$3.510B to $3.450B-$3.520B vs $3.463B Est AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $3.440 billion-$3.510 billion to $3.450 billion-$3.520 billion vs $3.463 billion estimate.
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $14 Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 to $14.- benzinga.com Leerink Partners Maintains Outperform on AdaptHealth, Lowers Price Target to $12 Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $13 to $12.
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com AdaptHealth Q4 Earnings Report: What Investors Need to Know 
benzinga.com AdaptHealth Earnings Report: Q4 Overview - benzinga.com AdaptHealth Q4 Adj. EPS $0.19 Misses $0.35 Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.35 by 45.71 percent. This is a 44.12 percent decrease over earnings of $0.34…
- benzinga.com AdaptHealth Sees FY2026 Sales $3.440B-$3.510B vs $3.441B Est Guidance for Fiscal Year 2026While fourth quarter 2025 Adjusted EBITDA was impacted by a legal settlement expense of $14.5 million and over $10 million of strategic investments to accelerate…
- benzinga.com AdaptHealth Q4 Sales $846.289M Beat $831.610M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $846.289 million which beat the analyst consensus estimate of $831.610 million by 1.77 percent. This is a 1.21 percent decrease over sales of…
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com Exploring AdaptHealth's Earnings Expectations - benzinga.com Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $15 Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $15.
- benzinga.com AdaptHealth Affirms FY2025 Sales Guidance of $3.180B-$3.260B vs $3.225B Est AdaptHealth (NASDAQ:AHCO) affirms FY2025 sales outlook from $3.180 billion-$3.260 billion to $3.180 billion-$3.260 billion vs $3.225 billion estimate.
- benzinga.com AdaptHealth Q3 EPS $0.16 Misses $0.23 Estimate, Sales $820.314M Beat $799.311M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.23 by 31.33 percent. This is a 5.88 percent decrease over earnings of $0.17…
benzinga.com Earnings Scheduled For November 4, 2025 - benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
- benzinga.com AdaptHealth Narrows FY2025 Sales Guidance from $3.150B-$3.290B to $3.180B-$3.260B vs $3.252B Est Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025, as follows:Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billionAdjusted EBITDA…
- benzinga.com Earnings Scheduled For August 5, 2025
- benzinga.com AdaptHealth Closes Disposition Of Certain Infusion Assets In Wellness At Home Segment; Uses Sale Proceeds To Pay Down $65M In Debt AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and…
- benzinga.com Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session